SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Peponis, V
Right arrow Articles by Sitaras, N M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peponis, V
Right arrow Articles by Sitaras, N M
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Eye Diseases
*Lupus
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Ocular manifestations of systemic lupus erythematosus: a clinical review

V Peponis

Department of Ophthalmology, General Hospital of Piraeus ‘Tzaneion’, Greece, Department of Pharmacology, Medical School, University of Athens, Greece

V C Kyttaris

Department of Cellular Injury, Walter Reed Army Institute of Research, Silver Spring, MD, USA, vasileios.kyttaris{at}na.amedd.army.mil

C Tyradellis

Department of Ophthalmology, General Hospital of Piraeus ‘Tzaneion’, Greece

I Vergados

2nd University Eye Clinic, Medical School, University of Athens, Greece

N M Sitaras

Department of Pharmacology, Medical School, University of Athens, Greece

Although the eye itself is regarded an ‘immune-privileged’ organ, systemic lupus erythematosus (SLE) can affect every ocular structure, leading, if left untreated, to significant visual loss or even blindness. Since ocular inflammation in SLE can antedate the diagnosis of the systemic disease and cause significant morbidity, prompt diagnosis and treatment of the underlying systemic autoimmune disease is imperative.

Key Words: antimalarials • keratoconjunctivitis sicca • retina • scleritis • systemic lupus erythematosus

Lupus, Vol. 15, No. 1, 3-12 (2006)
DOI: 10.1191/0961203306lu2250rr


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
C Lopez-Pedrera, N Barbarroja, M. Aguirre, L. Torres, F Velasco, and M. Cuadrado
Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases
Lupus, October 1, 2008; 17(10): 905 - 916.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
R. R. Sivaraj, O. M. Durrani, A. K. Denniston, P. I. Murray, and C. Gordon
Ocular manifestations of systemic lupus erythematosus
Rheumatology, December 1, 2007; 46(12): 1757 - 1762.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. G. Joseph, G. A. Lammie, and N. J. Scolding
CNS lupus: A study of 41 patients
Neurology, August 14, 2007; 69(7): 644 - 654.
[Abstract] [Full Text] [PDF]



Advertisement